Results 21 to 30 of about 1,163 (152)

Deprescribing medicines in an intensive care unit of a university hospital from Ceará

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2022
Objectives: To evaluate the pharmaceutical deprescription recommendations made to patients hospitalized in an adult clinical Intensive Care Unit (ICU). Methods: This is a cross-sectional, descriptive, and quantitative study developed with pharmaceutical ...
Ana V. OLIVEIRA   +8 more
doaj   +1 more source

The Risk of Drug Interactions in Older Primary Care Patients after Hospital Discharge: The Role of Drug Reconciliation

open access: yesGeriatrics, 2023
Introduction: Drug–drug interactions (DDIs) represent an important clinical problem, particularly in older patients, due to polytherapy, comorbidity, and physiological changes in pharmacodynamic and pharmacokinetic pathways.
Cristina Vocca   +19 more
doaj   +1 more source

The process of deprescribing in older adults: a methodological protocol

open access: yesGeriatrics, Gerontology and Aging, 2022
Objective: To report, by means of a methodological protocol, the process of deprescribing implemented in a geriatric psychiatry outpatient clinic of a teaching hospital.
Natascha Melo Linkievicz   +3 more
doaj   +1 more source

Deprescribing benzodiazepines: Do Brazilian package inserts address this issue?

open access: yesGeriatrics, Gerontology and Aging, 2021
OBJECTIVE: To analyze the presence and quality of content on drug deprescribing in Brazilian package inserts for benzodiazepine drugs. METHODS: Documentary study where we analyzed data on deprescribing extracted from electronic package inserts of drugs ...
Marlon Silva Tinoco   +7 more
doaj   +1 more source

The Elderly’s Thoughts and Attitudes about Polypharmacy and Deprescribing: A Qualitative Pilot Study in Portugal [PDF]

open access: yes, 2022
The high prevalence of polypharmacy and potentially inappropriate medications in the elderly makes them a vulnerable group to adverse drug events. Deprescribing is the medication review plus cessation of potentially inappropriate medications with a ...
Foreman, Nicole   +6 more
core   +1 more source

Drug deprescription—withdrawal risk, prevention, and treatment [PDF]

open access: yesBaylor University Medical Center Proceedings, 2019
In most cases, a sudden interruption of most medications has no major consequences. There are well-recognized therapies that, when withheld, can either lead to the reappearance of the symptoms they were controlling or to signs or symptoms of withdrawal.
Madison K. Bangert, Gabriel M. Aisenberg
openaire   +3 more sources

Uso práctico de inhibidores de bomba de protones

open access: yesMedicina U.P.B., 2022
Los inhibidores de la bomba de protones (IBP) se encuentran entre los medicamentos más utilizados en el mundo por su bajo costo, extensa prescripción y efectividad.
Nicolás Zuluaga Arbeláez   +2 more
doaj   +1 more source

When less is more: deprescription in a long-stay hospital. A case report

open access: yesEuropean Psychiatry, 2022
Introduction We present the case of a 54-year-old man diagnosed with mixed histrionic / obssesive personality disorder admitted in a long-stay hospital.
R. De Hita Santillana   +2 more
doaj   +1 more source

El reto del envejecimiento y la complejidad farmacoterapéutica en el paciente VIH+ [PDF]

open access: yes, 2018
Objective: To describe the current knowledge and management of aging and pharmacotherapeutic complexity in HIV + patients. Method: A review of literature was carried out, including articles, originals or reviews, published in English or Spanish, from ...
Abdel Kader Martín, Laila   +3 more
core   +3 more sources

Polypharmacy in elderly cancer patients : challenges and the way clinical pharmacists can contribute in resource-limited settings [PDF]

open access: yes, 2019
The aim of this study was to address the problems associated with polypharmacy in elderly cancer patients and to highlight the role of pharmacists in such cases in resource‐limited settings.
Khanal, Saval   +2 more
core   +2 more sources

Home - About - Disclaimer - Privacy